Thigh pain spans four emergencies that a muscular label can hide: venous (proximal DVT, which can throw a fatal PE), arterial (acute ischaemia — limb viable only for about six hours), pressure (compartment syndrome) and infective (necrotising fasciitis). Each has a simple discriminator — unilateral swelling with VTE risk, the 6 Ps, pain out of proportion, and systemic toxicity — and each needs same-hour action rather than analgesia and review.
NICE NG12 makes bone and soft-tissue sarcoma a primary-care responsibility. The femur is a classic site for osteosarcoma in younger patients. Persistent deep bone pain — particularly waking the patient at night — or an enlarging mass warrants an urgent X-ray, and an X-ray suggestive of sarcoma triggers a 48-hour referral; a normal X-ray with ongoing suspicion still needs repeat imaging or referral.
The history alone usually localises thigh pain to one of five compartments — vascular, neurogenic, muscular, referred (hip/spine) or bone — which is what determines the right investigation. A radicular description points to the lumbar spine and an MRI, a claudication history to the arteries and an ABPI, and a deep night-pain history to bone and an X-ray.
Two drug-specific traps are worth a deliberate question. Long-term bisphosphonate use can cause an atypical femoral fracture, classically heralded by weeks of dull thigh or groin pain before the bone breaks; and statins cause a spectrum from benign myalgia to rare necrotising myositis, so a CK is part of the work-up when muscle pain is diffuse.
Because the thigh refers pain from the spine above and the hip and knee below, the examination must deliberately include all three plus the nerves and vessels that cross it. A normal local muscle examination with pain reproduced on hip movement reclassifies the problem entirely, as does an absent pulse or a focal neurological deficit.
Measuring limb circumference and assessing compartment tension are quick, objective steps that separate a benign strain from the two pressure-related emergencies — a swelling DVT and an evolving compartment syndrome — where the diagnosis turns on asymmetry and pain out of proportion rather than on the appearance of the skin.
Grouping the differential by tissue of origin keeps the dangerous diagnoses visible next to the common ones: every column contains both a benign cause (strain, meralgia, claudication you can manage) and a red-flag (sarcoma, ischaemia, fracture), so the framework itself prompts you not to anchor on muscle.
Two under-recognised diagnoses sit specifically in the thigh: meralgia paraesthetica, a purely sensory entrapment of the lateral femoral cutaneous nerve that needs reassurance rather than imaging, and diabetic amyotrophy, a painful proximal motor neuropathy with quadriceps wasting that is easily mistaken for a structural hip or spine problem.
Investigation follows the localisation rather than scatter-gun testing: a Wells score directs the DVT pathway, an ABPI confirms PAD, a plain X-ray screens bone, and MRI is reserved for neurological deficit, occult fracture or a mass. The single most important rule is that a high clinical probability of DVT goes straight to ultrasound — a D-dimer cannot exclude it.
A normal X-ray never excludes a sarcoma or an early stress fracture. If deep bone pain persists, MRI (or referral) is the next step, because both diagnoses are radiographically silent in their early weeks and the cost of a missed bone tumour is measured in stages.
The referral routes mirror the red-flag list: vascular and infective emergencies bypass investigation entirely, while the two NG12 sarcoma pathways (bone via urgent X-ray then 48-hour referral, soft tissue via ultrasound then 2-week-wait) are the cancer safety net that primary care owns for limb pain.
Suspected atypical femoral fracture deserves urgent orthopaedic discussion in its own right: the prodromal thigh-pain phase is the window to protect the bone (stop the bisphosphonate, restrict loading, image both femora) before a complete, poorly-healing fracture occurs.
Most thigh pain is mechanical and self-limiting, and the evidence supports active management — graded loading for muscle injury and a supervised exercise programme for claudication — over rest and escalating analgesia. Opioids have a small, short-term role and no place in the chronic management of mechanical or neuropathic limb pain.
Naming the diagnosis changes the treatment: meralgia paraesthetica responds to offloading the nerve and reassurance rather than imaging or surgery, and diabetic amyotrophy needs glycaemic control and time rather than orthopaedic referral. Setting realistic timelines — months, not weeks — prevents repeat presentations and inappropriate escalation.
The lifestyle measures are not generic advice — each maps onto a specific cause: load management for tendons and muscle, energy availability and bone health for stress fractures, and the cardiovascular risk-factor package for claudication, where the leg is a marker of systemic atherosclerosis and the priority is preventing MI and stroke.
Equipping at-risk patients to recognise DVT and PE symptoms shortens the time to treatment for the one thigh-pain diagnosis most likely to kill, and is a high-value, low-effort piece of every relevant consultation.
Specific, symptom-level safety-netting is what makes a probable-strain label safe: the patient leaves knowing exactly which changes (a swelling or breathless episode, a cold leg, spreading redness and fever, new weakness or bladder symptoms) mean same-day or 999 review, rather than a vague instruction to come back if no better.
A planned review interval matched to the expected recovery turns safety-netting into active follow-up. Pain that fails to settle on the expected trajectory is a prompt to re-open the differential — re-examine, re-image, reconsider sarcoma or stress fracture — not to escalate analgesia on an unconfirmed diagnosis.